Device Trial Radar · NCT01820130
Trial of Autonomic neuroModulation for trEatment of Chronic Heart Failure
Last checked: Nov 19, 2026Latest source record: Feb 4, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Withdrawn
Enrollment
0
Actual
Start
Mar 2013
Primary completion
Sep 2016
Study completion Sep 2016
Sponsor
- Lead sponsor
- Abbott Medical DevicesPublic (ABT)
- Sponsor type
- Industry
- First posted
- Mar 28, 2013
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this clinical investigation is to evaluate the safety and efficacy of Spinal Cord Stimulation (SCS) in advanced heart failure (HF) patients with Implantable Cardioverter Defibrillator (ICD) but not indicated for Cardiac Resynchronization Therapy (CRT).
Conditions
- Heart Failure
Interventions
St Jude Medical EON mini rechargeable systemDevice
implantation of Eon Mini Neurostimulation System (IPG Model 3788)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Efficacy Marker of Cardiac remodeling via Left Ventricular End Diastolic Volume (LVEDV) of Patient with advanced HFTime frame: baseline and 6 Months
- Efficacy Marker of patient symptom via NYHA class for patient with advanced HFTime frame: Baseline and 6 months
- Efficacy Marker of patient symptom via 6 Minutes Hall Walk distance for patient with advanced HFTime frame: baseline to 6 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
CHU
Pessac, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.